Z
Zynerba Pharmaceuticals Inc
F:6ZY
Zynerba Pharmaceuticals Inc
F:6ZY
Price:
1.26
EUR
2.44%
Market Cap:
€67.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zynerba Pharmaceuticals Inc
F:6ZY
|
US |
|
Aero Energy Ltd
F:J5B
|
CA |
|
N
|
New Hope Service Holdings Ltd
HKEX:3658
|
CN |
|
U
|
Universal Music Group NV
OTC:UMGNF
|
NL |
|
Lancaster Colony Corp
NASDAQ:LANC
|
US |
|
Surrozen Inc
NASDAQ:SRZN
|
US |
|
C
|
Creotech Instruments SA
WSE:CRI
|
PL |
|
Yeahka Ltd
HKEX:9923
|
CN |
|
Howmet Aerospace Inc
NYSE:HWM
|
US |
|
Clever Leaves Holdings Inc
OTC:CLVR
|
CO |
|
Shopify Inc
NASDAQ:SHOP
|
CA |
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
US |
|
S
|
S P Setia Bhd
KLSE:SPSETIA
|
MY |
|
Pnb Gilts Ltd
NSE:PNBGILTS
|
IN |
|
Altin Yunus Cesme Turistik Tesisler AS
IST:AYCES.E
|
TR |
|
Lunai Bioworks Inc
NASDAQ:LNAI
|
US |
|
C
|
Chengdu RML Technology Co Ltd
SZSE:301050
|
CN |
|
Bel Fuse Inc
NASDAQ:BELFA
|
US |
|
A
|
Agnico Eagle Mines Ltd
NYSE:AEM
|
CA |
|
Arvind Smartspaces Ltd
NSE:ARVSMART
|
IN |
|
Akasol AG
XETRA:ASL
|
DE |
|
Silver Tiger Metals Inc
XTSX:SLVR
|
CA |
|
Gritstone bio Inc
NASDAQ:GRTS
|
US |
|
T
|
Terranet AB
STO:TERRNT B
|
SE |
Balance Sheet
Balance Sheet Decomposition
Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals Inc
Balance Sheet
Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
9
|
42
|
31
|
63
|
60
|
70
|
59
|
68
|
51
|
|
| Cash Equivalents |
0
|
9
|
42
|
31
|
63
|
60
|
70
|
59
|
68
|
51
|
|
| Total Receivables |
0
|
0
|
0
|
4
|
4
|
3
|
15
|
9
|
10
|
1
|
|
| Other Current Assets |
1
|
2
|
2
|
2
|
2
|
4
|
2
|
5
|
3
|
3
|
|
| Total Current Assets |
1
|
12
|
43
|
36
|
68
|
67
|
87
|
73
|
80
|
55
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
12
+525%
|
44
+276%
|
37
-16%
|
69
+89%
|
67
-2%
|
88
+30%
|
74
-16%
|
81
+10%
|
56
-32%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
1
|
2
|
3
|
4
|
5
|
3
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
2
|
4
|
4
|
5
|
7
|
11
|
8
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
3
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
4
|
7
|
7
|
10
|
12
|
14
|
10
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
3
+3%
|
4
+25%
|
7
+77%
|
8
+16%
|
10
+20%
|
12
+25%
|
14
+14%
|
10
-26%
|
9
-9%
|
|
| Equity | |||||||||||
| Common Stock |
3
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
10
|
23
|
46
|
78
|
118
|
151
|
202
|
239
|
275
|
|
| Additional Paid In Capital |
0
|
2
|
62
|
76
|
139
|
175
|
226
|
262
|
310
|
321
|
|
| Total Equity |
1
N/A
|
8
N/A
|
40
+369%
|
30
-25%
|
61
+106%
|
58
-5%
|
76
+31%
|
60
-20%
|
71
+18%
|
46
-35%
|
|
| Total Liabilities & Equity |
2
N/A
|
12
+525%
|
44
+276%
|
37
-16%
|
69
+89%
|
67
-2%
|
88
+30%
|
74
-16%
|
81
+10%
|
56
-32%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
9
|
9
|
9
|
10
|
14
|
18
|
23
|
30
|
41
|
48
|
|
Switch to:
Switch to:
See Also
Discover More
